Critical Care
To help improve outcomes, patients in the ICU require early and appropriate nutrition based on their condition/diagnosis. Abbott Nutrition can assist you in providing the appropriate formula to meet your patients’ specific nutritional needs. An algorithm published in 2011 can provide guidance on how, when, and what to feed your patients based on clinical conditions.1 Other Critical Care Guidelines 2,3 may also be helpful in guiding you in selecting the appropriate product that will meet your patients' individual needs.
Clinical Studies in the ICU
Nutrition Studies in the ICU
A helpful summary of clinical studies related to the critically ill being treated in the ICU.
Abbott Nutrition Product Studies in the ICU
A helpful summary of clinical studies concerning the effectiveness of Abbott Nutrition’s products being used within the ICU.
Clinical Study – Vital
Feeding a peptide-based enteral formula to critically ill patients can promote feeding tolerance compared to a polymeric enteral formula. A poster and abstract presented at Clinical Nutrition Week (CNW) in 2015 showed that patients in the ICU who were fed Vital AF 1.2 Cal experienced fewer days of GI complications and fewer days of distension compared to patients who were fed Osmolite.
Clinical Summary - Oxepa
Oxepa has been studied in patients on mechanical ventilation with SIRS, ALI, and ARDS. The INTERSEPT Study published in 2011 provides evidence that use of an enteral formula with EPA, GLA, and elevated antioxidants (Oxepa) in patients with early stages of sepsis without any organ failure can slow the progression of the disease to severe sepsis and/or septic shock.4
Clinical Summary - Pivot
An abstract and poster presented at CNW in 2011 highlighted fewer infectious complications and decreased hospital length of stay in post-operative cardiac surgery patients when using Pivot 1.5 Cal vs. standard enteral formulations with no fish oil or added arginine.5